Skip to main content
. Author manuscript; available in PMC: 2019 Aug 30.
Published in final edited form as: J Med Genet. 2019 Feb 11;56(6):370–379. doi: 10.1136/jmedgenet-2018-105361

Table 2.

OR of a given domain versus other domains including 95% CIs and p values by logistic regression of domain of truncating CDH1 variant and clinical phenotype

Colorectal cancer
Domain Estimate 2.5% 97.5% P value

PRE-PRO 6.20 1.79 21.477 0.004
EC 1 and 2 NA NA NA NA
EC 3, 4 and 5 0.872 0.252   3.021 0.8287
IC 1.622 0.445   5.91 0.4632
Linker 0.351 0.073 1.681 0.1902
Breast cancer
PRE-PRO 2.545 0.793   8.171 0.1164
EC 1 and 2 0.685 0.222   2.115 0.5104
EC 3,4 and 5 2.038 0.775   5.36 0.1488
IC 0.821 0.277   2.437 0.7223
Linker 0.346 0.12   0.993 0.0493
Affected family members at young age*
PRE-PRO 1.444 0.292   7.136 0.6518
EC 1 and 2 NA NA NA NA
EC 3, 4 and 5 0.683 0.209   2.226 0.5269
IC 0.195 0.059   0.641 0.0071
Linker 2.333 0.486 11.213 0.2901
*

Gastric cancer at <40 years or lobular breast cancer <50 years.

EC, extracellular; IC, intracellular; NA, too few counts to calculate OR.